BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28854316)

  • 1. Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases.
    Yamashita S; Venkatesan AM; Mizuno T; Aloia TA; Chun YS; Lee JE; Vauthey JN; Conrad C
    JAMA Surg; 2017 Oct; 152(10):e172986. PubMed ID: 28854316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Remnant Liver Ischemia With Early Recurrence and Poor Survival After Liver Resection in Patients With Hepatocellular Carcinoma.
    Cho JY; Han HS; Choi Y; Yoon YS; Kim S; Choi JK; Jang JS; Kwon SU; Kim H
    JAMA Surg; 2017 Apr; 152(4):386-392. PubMed ID: 28052154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status.
    Yamashita S; Sheth RA; Niekamp AS; Aloia TA; Chun YS; Lee JE; Vauthey JN; Conrad C
    Ann Surg; 2017 Dec; 266(6):1045-1054. PubMed ID: 27735824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.
    Kawaguchi Y; Lillemoe HA; Panettieri E; Chun YS; Tzeng CD; Aloia TA; Kopetz S; Vauthey JN
    J Am Coll Surg; 2019 Sep; 229(3):286-294.e1. PubMed ID: 31054911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases.
    Zhai Y; Bai W; Zhou J; Dong Q; Zhang J
    BMC Cancer; 2022 Jan; 22(1):103. PubMed ID: 35078439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.
    Odisio BC; Yamashita S; Huang SY; Kopetz SE; Ahrar K; Mizuno T; Conrad C; Aloia TA; Chun YS; Gupta S; Vauthey JN
    J Vasc Interv Radiol; 2018 Mar; 29(3):395-403.e1. PubMed ID: 29395898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study.
    Chok KS; Cheung TT; Chan AC; Dai WC; Chan SC; Fan ST; Poon RT; Lo CM
    ANZ J Surg; 2014; 84(7-8):545-9. PubMed ID: 23809019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases.
    van Dam RM; Lodewick TM; van den Broek MA; de Jong MC; Greve JW; Jansen RL; Bemelmans MH; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2014 Jun; 16(6):550-9. PubMed ID: 24246003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based Study.
    Booth CM; Nanji S; Wei X; Mackillop WJ
    JAMA Oncol; 2015 Nov; 1(8):1111-9. PubMed ID: 26355283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Kawaguchi Y; Kopetz S; Tran Cao HS; Panettieri E; De Bellis M; Nishioka Y; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Hasegawa K; Guglielmi A; Giuliante F; Vauthey JN
    Br J Surg; 2021 Aug; 108(8):968-975. PubMed ID: 33829254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryologic Origin of the Primary Tumor and RAS Status Predict Survival after Resection of Colorectal Liver Metastases.
    Alexandrescu ST; Dinu IM; Diaconescu AS; Micu A; Pasare E; Durdu C; Dorobantu BM; Popescu I
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation of portal/hepatic vein associated remnant liver ischemia/congestion by three-dimensional visualization technology based on preoperative CT scan.
    Li XL; Xu B; Zhu XD; Huang C; Shi GM; Shen YH; Wu D; Tang M; Tang ZY; Zhou J; Fan J; Sun HC
    Ann Transl Med; 2021 May; 9(9):756. PubMed ID: 34268369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of the resection severity index as independent risk factor limiting survival after resection of colorectal liver metastases.
    Gwiasda J; Schrem H; Kaltenborn A; Mahlmann J; Mix H; Lehner F; Kayser N; Klempnauer J; Kulik U
    Surg Oncol; 2017 Dec; 26(4):382-388. PubMed ID: 29113656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.